Mr Mrs Miss Ms Dr Other

Miss
Joanna
Pownall

Senior Patent Attorney

Manchester Office

Chemistry

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Joanna graduated from the University of Durham with a First Class MChem Honours degree in Chemistry.

In 2006 Joanna joined a major global pharmaceutical company and worked in their late-stage research and development department firstly as an analytical chemist and then as a solid state scientist. Joanna worked on a number of late stage pharmaceutical projects with multi-discipline project teams. Joanna helped define the solid state strategies, such as the selection of a suitable physical form and the control of the physical form, for a number of projects. Joanna also authored the solid state sections of regulatory submissions.

In September 2014 Joanna joined the in-house IP department of the pharmaceutical company. During her time in this department, Joanna gained experience in patent drafting and prosecution. Joanna was responsible for managing the IP portfolio of a number of early and late-stage pharmaceutical projects.

Joanna joined HGF’s Manchester office in October 2017 and has worked with a number of different clients including pharmaceutical companies and Universities. Joanna has been involved with preparing submissions for opposition and appeal proceedings before the EPO.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MCHEM

MChem in Chemistry

Related News

Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Basics of trade mark protection - National and European perspectives

HGF is pleased to invite you to our upcoming German speaking seminar on “Fundamentals of trade mark protection: National and European Perspectives” in Salzburg and Dresden. The seminar will cover …

Event details

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.